Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)

ClinicalTrials.gov ID: NCT04451330

Public ClinicalTrials.gov record NCT04451330. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 8:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study To Compare Efficacy and Safety of Trifarotene (CD5789) Cream When Used Withan Oral Antibiotic for the Treatment of Severe Acne Vulgaris

Study identification

NCT ID
NCT04451330
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Galderma R&D
Industry
Enrollment
202 participants

Conditions and interventions

Conditions

Interventions

  • Trifarotene cream Drug
  • Doxycycline hyclate Drug
  • Trifarotene Vehicle Drug
  • Doxycycline Placebo Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 28, 2020
Primary completion
Apr 25, 2021
Completion
Apr 25, 2021
Last update posted
May 9, 2022

2020 – 2021

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
Galderma Investigational Site Fort Smith Arkansas 72916
Galderma Investigational Site Hot Springs Arkansas 71913
Galderma Investigational Site Rogers Arkansas 72758
Galderma Investigational Site Newport Beach California 92663
Galderma Investigational Site Aventura Florida 33180
Galderma Investigational Site Boca Raton Florida 33486
Galderma Investigational Site Miramar Florida 33027
Galderma Investigational Site Newnan Georgia 30263
Galderma Investigational Site Evansville Indiana 47715
Galderma Investigational Site New Albany Indiana 47150
Galderma Investigational Site Rockville Maryland 20850
Galderma Investigational Site Warren Michigan 48088
Galderma Investigational Site New Brighton Minnesota 55112
Galderma Investigational Site Las Vegas Nevada 89148
Galderma Investigational Site Stony Brook New York 11790
Galderma Investigational Site High Point North Carolina 27262
Galderma Investigational Site Sugarloaf Pennsylvania 18249
Galderma Investigational Site Charleston South Carolina 71913
Galderma Investigational Site Knoxville Tennessee 37922
Galderma Investigational Site Arlington Texas 76011
Galderma Investigational Site Dallas Texas 75246
Galderma Investigational Site Grapevine Texas 76051
Galderma Investigational Site Pflugerville Texas 78660
Galderma Investigational Site San Antonio Texas 78218
Galderma Investigational Site San Antonio Texas 78249

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04451330, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2022 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04451330 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →